Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immuron Ltd ADR (NQ: IMRN ) 2.640 -0.060 (-2.22%) Streaming Delayed Price Updated: 3:58 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Immuron Ltd ADR < Previous 1 2 3 4 5 Next > Immuron announces record Travelan® sales globally, Australia and USA July 15, 2024 From Immuron Limited Via GlobeNewswire Immuron requests pre-IND meeting for IMM-529 with FDA filing July 02, 2024 From Immuron Limited Via GlobeNewswire Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference June 05, 2024 From Immuron Limited Via GlobeNewswire Immuron Board Changes May 31, 2024 From Immuron Limited Via GlobeNewswire Immuron CEO Steven Lydeamore to present at Peak Sky High May 31, 2024 From Immuron Limited Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 08, 2024 Via Benzinga Immuron Limited to Present at the Emerging Growth Conference May 07, 2024 From Immuron Limited Via GlobeNewswire Immuron Director Resignation May 03, 2024 From Immuron Limited Via GlobeNewswire Immuron to host Live Virtual Event April 15, 2024 From Immuron Limited Via GlobeNewswire Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 10, 2024 Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6 million public offering of shares at $0.14 per share. Via Benzinga Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket April 10, 2024 Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter. Via Benzinga Immuron Travelan® sales continued strong growth April 10, 2024 From Immuron Limited Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Pre-Market Session March 28, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session March 11, 2024 Via Benzinga Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 11, 2024 Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart... Via Benzinga Exposures Product Safety Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket March 11, 2024 Shares of Fangdd Network Group Ltd. (NASDAQ: DUO) rose sharply in today’s pre-market trading after the company announced its 2024 strategic layout with plans to enter the real estate stock asset... Via Benzinga Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session March 08, 2024 Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session March 08, 2024 Via Benzinga Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket March 08, 2024 Shares of Porch Group, Inc. (NASDAQ: PRCH) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance. Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session March 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session March 07, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday March 07, 2024 Pre-market stock movers are worth checking out on Thursday to get an idea of the hottest stocks worth watching this morning! Via InvestorPlace Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US March 07, 2024 From Immuron Limited Via GlobeNewswire Immuron Presentation Australian Biologics Festival 2024 February 21, 2024 From Immuron Limited Via GlobeNewswire Immuron achieves record Travelan® sales February 13, 2024 From Immuron Limited Via GlobeNewswire Immuron CEO, Steven Lydeamore Investor Webinar Presentation February 08, 2024 From Immuron Limited Via GlobeNewswire Immuron achieves record half yearly Travelan® sales January 16, 2024 From Immuron Limited Via GlobeNewswire Immuron Clinical Trials Update December 22, 2023 From Immuron Limited Via GlobeNewswire Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study December 04, 2023 From Immuron Limited Via GlobeNewswire Immuron CEO, Steven Lydeamore Investor Webinar Presentation November 28, 2023 From Immuron Limited Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.